Revolution Medicines, Inc. RVMD Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Revolution Medicines, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Revolution Medicines, Inc.'s free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Revolution Medicines, Inc.'s free cash flow yield?
- Revolution Medicines, Inc. (RVMD) reported free cash flow yield of -5.6% in Q1 2026.
- How has Revolution Medicines, Inc.'s free cash flow yield changed year-over-year?
- Revolution Medicines, Inc.'s free cash flow yield increased by 39.2% year-over-year, from -9.2% to -5.6%.
- What is the long-term trend for Revolution Medicines, Inc.'s free cash flow yield?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s free cash flow yield has grown at a 8.5% compound annual growth rate (CAGR), from -24.1% to -33.4%.
- What does free cash flow yield mean?
- The spendable cash the business throws off each year as a percentage of its market price.
- How do you interpret free cash flow yield?
- Higher yield can mean better value — you pay less for each dollar of cash generated. A useful sanity check against earnings-based multiples, which non-cash items can distort.
- How does free cash flow yield compare across companies?
- Comparable across cash-generative companies; less meaningful for firms in heavy-investment phases with temporarily negative FCF.